BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20863864)

  • 1. Neuropeptide Y conjugated to saporin alters anxiety-like behavior when injected into the central nucleus of the amygdala or basomedial hypothalamus in BALB/cJ mice.
    Lyons AM; Thiele TE
    Peptides; 2010 Dec; 31(12):2193-9. PubMed ID: 20863864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basomedial hypothalamic injections of neuropeptide Y conjugated to saporin selectively disrupt hypothalamic controls of food intake.
    Bugarith K; Dinh TT; Li AJ; Speth RC; Ritter S
    Endocrinology; 2005 Mar; 146(3):1179-91. PubMed ID: 15604214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors.
    Primeaux SD; Wilson SP; Cusick MC; York DA; Wilson MA
    Neuropsychopharmacology; 2005 Sep; 30(9):1589-97. PubMed ID: 15770236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y receptor-expressing dorsal horn neurons: role in nocifensive reflex responses to heat and formalin.
    Wiley RG; Lemons LL; Kline RH
    Neuroscience; 2009 Jun; 161(1):139-47. PubMed ID: 19138726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
    Karlsson RM; Choe JS; Cameron HA; Thorsell A; Crawley JN; Holmes A; Heilig M
    Psychopharmacology (Berl); 2008 Jan; 195(4):547-57. PubMed ID: 17891380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.
    Sparrow AM; Lowery-Gionta EG; Pleil KE; Li C; Sprow GM; Cox BR; Rinker JA; Jijon AM; Peňa J; Navarro M; Kash TL; Thiele TE
    Neuropsychopharmacology; 2012 May; 37(6):1409-21. PubMed ID: 22218088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
    Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion of NPY Receptor-expressing Neurons in Perifornical Lateral Hypothalamus Attenuates Glucoprivic Feeding.
    Choi PP; Wang Q; Brenner LA; Li AJ; Ritter RC; Appleyard SM
    Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38368624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
    Kokare DM; Dandekar MP; Chopde CT; Subhedar N
    Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-specific expression of calcineurin immunoreactivity within the rat basolateral amygdala complex and colocalization with the neuropeptide Y Y1 receptor.
    Leitermann RJ; Sajdyk TJ; Urban JH
    J Chem Neuroanat; 2012 Oct; 45(1-2):50-6. PubMed ID: 22884996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of neuropeptide Y1 receptors in the amygdala and hippocampus and anxiety-like behavior associated with Ammon's horn sclerosis following intrahippocampal kainate injection in C57BL/6J mice.
    O'Loughlin EK; Pakan JM; McDermott KW; Yilmazer-Hanke D
    Epilepsy Behav; 2014 Aug; 37():175-83. PubMed ID: 25050777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats.
    Zhang H; Sakharkar AJ; Shi G; Ugale R; Prakash A; Pandey SC
    Alcohol Clin Exp Res; 2010 Mar; 34(3):451-61. PubMed ID: 20028368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
    Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
    Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
    Heilig M
    Regul Pept; 1995 Oct; 59(2):201-5. PubMed ID: 8584755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse.
    Broberger C; Visser TJ; Kuhar MJ; Hökfelt T
    Neuroendocrinology; 1999 Nov; 70(5):295-305. PubMed ID: 10567855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol-induced anxiolysis and neuronal activation in the amygdala and bed nucleus of the stria terminalis.
    Sharko AC; Kaigler KF; Fadel JR; Wilson MA
    Alcohol; 2016 Feb; 50():19-25. PubMed ID: 26775553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.
    Wierońska JM; Szewczyk B; Pałucha A; Brański P; Zieba B; Smiałowska M
    Pharmacol Rep; 2005; 57(6):734-43. PubMed ID: 16382191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.
    Christiansen SH; Olesen MV; Gøtzsche CR; Woldbye DP
    Neuropeptides; 2014 Dec; 48(6):335-44. PubMed ID: 25267070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.
    Fendt M; Bürki H; Imobersteg S; Lingenhöhl K; McAllister KH; Orain D; Uzunov DP; Chaperon F
    Psychopharmacology (Berl); 2009 Oct; 206(2):291-301. PubMed ID: 19609506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.